Trials / Completed
CompletedNCT00150605
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Validus Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of SPD417 when given with other psychotropic medications to treat bipolar I disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Extended-release carbamazepine |
Timeline
- Start date
- 2005-02-01
- Completion
- 2005-10-01
- First posted
- 2005-09-08
- Last updated
- 2007-11-02
Source: ClinicalTrials.gov record NCT00150605. Inclusion in this directory is not an endorsement.